# Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose

> **NCT01367496** · PHASE1 · COMPLETED · sponsor: **Bausch Health Americas, Inc.** · enrollment: 6 (actual)

## Conditions studied

- Healthy Subjects

## Interventions

- **DRUG:** SC Methylnaltrexone (MNTX)
- **DRUG:** SC Methylnaltrexone (MNTX)
- **DRUG:** SC Methylnaltrexone (MNTX)
- **DRUG:** IV Methylnaltrexone (MNTX)

## Key facts

- **NCT ID:** NCT01367496
- **Lead sponsor:** Bausch Health Americas, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-06
- **Primary completion:** 2002-08
- **Final completion:** 2002-08
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2019-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367496

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367496, "Pharmacokinetics and Bioavailability of Single Subcutaneous Doses of Methylnaltrexone Versus Intravenous Dose". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01367496. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*